Primary Prevention of Stroke in Children with Sickle Cell Anaemia in Nigeria: Community vs Teaching Hospital
Project Number5K43TW011583-05
Contact PI/Project LeaderBELLO-MANGA, HALIMA
Awardee OrganizationBARAU DIKKO TEACHING HOSPITAL/ KADUNA STATE UNIVERSITY
Description
Abstract Text
ABSTRACT
Stroke is a frequent complication of sickle cell anemia (SCA) that is associated with increased morbidity
and mortality. Without any intervention, ~11% of children with SCA will develop stroke before their 17th
birthday. Evidence-based practices for primary stroke prevention include screening for abnormal
transcranial Doppler (TCD) measurements coupled with regular blood transfusion therapy for at least one
year, then hydroxyurea therapy for an indefinite period. In high-resource countries this strategy has
dropped stroke incidence rates by 92%. In Nigeria, approximately 150,000 children with SCA are born
annually, accounting for more than half of the total births with SCA worldwide. In comparison, there are only
1,700 affected births of children with SCA in the United States annually. Among each birth cohort, 15,000
children will have stroke annually in Nigeria. In 2016, as part of the capacity building objective of our Stroke
Prevention Trial in Nigeria (SPRING,1R01NS094041) at Barau Dikko Teaching Hospital (BDTH) in Kaduna,
TCD screening was adopted as standard of care. Before the trial, no TCD screening was performed at our
trial site. Currently as standard of care, physicians at BDTH perform TCD screening, however, only 5.4%
(1,101/20,040) of the eligible children with SCA living in Kaduna, Nigeria were reached. With just 21
radiologists and only 3 certified in TCD screening in Kaduna State, clearly, to achieve a decrease in stroke
incidence among children with SCA living in Kaduna, and elsewhere, we must have a better
implementation strategy to increase TCD screening. We therefore propose to initiate a stroke prevention
program in a community hospital in Kaduna, Nigeria by task-shifting TCD screening and stroke detection to
nurses. The aims of this proposal are to: 1) Identify barriers and facilitators that influence the adaptability of
the transported intervention, including implementation process; 2) Build capacity for stroke detection and
prevention in SCA in a community hospital; and 3) Conduct a feasibility trial comparing the effectiveness of
a physician-based primary stroke prevention program in a teaching hospital to a task-shifted primary stroke
prevention program in a community hospital.The proposed training and research will be conducted at Barau
Dikko Teaching Hospital and Yusuf Dantsoho Memorial hospital in Kaduna, Nigeria and will provide
preliminary data for a definitive randomized clinical trial in implementation science. A mentoring team of
senior researchers in United States and Nigeria will supervise the applicant. The mentoring team has
extensive research expertise in clinical trials in sickle cell disease and implementation science. The overall
research objective is to develop strategies that will improve primary prevention of strokes in children with
SCA.
Public Health Relevance Statement
Project Narrative
Stroke is a devastating complication of sickle cell anemia (SCA) still occurring in approximately 11% of
children affected with the disease in resource-limited countries, compared to 1% in high-income countries.
In Nigeria, the country with more than 50% of the global burden of SCA, screening for at risk children using
transcranial Doppler ultrasound (TCD) measurements is limited to tertiary hospitals. This mentored award
is focused on initiating a stroke prevention program in a resource-limited community hospital by task
shifting of TCD screening to nurses, a strategy that is expected to increase access for affected children with
prompt institution of a primary prevention strategy for those with increased stroke risk.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccountingAddressAdministratorAdoptedAffectAmerican Society of HematologyAwardBirthBloodBlood TransfusionCentral Nervous SystemCephalicCertificationChargeChildClinicalClinical TrialsCommunitiesCommunity HospitalsComplicationConsolidated Framework for Implementation ResearchCountryCoupledDataDetectionDiseaseDoseDropsEducationEffectivenessEligibility DeterminationEvidence based practiceFamilyFocus GroupsFundingGeneral PractitionersGoalsGuidelinesHealthHealth PersonnelHealthcareHospitalsHuman ResourcesIncidenceIncomeInstitutionInterventionInterviewLobbyingMeasurementMentorsMethodsMorbidity - disease rateNational Institute of Neurological Disorders and StrokeNeeds AssessmentNigeriaNursesOutcomeParticipantPatientsPhysiciansPreventionPrevention programPrevention strategyPrevention trialPrimary PreventionProcessQualitative MethodsRandom AllocationRandomized, Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceRecommendationResearchResearch PersonnelResource-limited settingResourcesRiskSafetyScientistSickle Cell AnemiaSiteState GovernmentStrokeStroke preventionTeaching HospitalsTestingTrainingTranscranial Doppler UltrasonographyUnited StatesWorld Health Organizationadherence rateburden of illnesscohortcompare effectivenessfeasibility trialhydroxyureaimplementation evaluationimplementation outcomesimplementation processimplementation scienceimplementation strategyimplementation/effectivenessimprovedinformantlow and middle-income countriesmortalitypediatricianprogramsradiologistrandomized, clinical trialsrecruitretention ratescreeningstandard carestandard of carestroke incidencestroke risk
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
989
DUNS Number
561295604
UEI
LALEULW37VK3
Project Start Date
01-August-2020
Project End Date
31-July-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$85,050
Direct Costs
$78,750
Indirect Costs
$6,300
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$50,000
2024
John E. Fogarty International Center for Advanced Study in the Health Sciences
$35,050
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K43TW011583-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K43TW011583-05
Patents
No Patents information available for 5K43TW011583-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K43TW011583-05
Clinical Studies
No Clinical Studies information available for 5K43TW011583-05
News and More
Related News Releases
No news release information available for 5K43TW011583-05
History
No Historical information available for 5K43TW011583-05
Similar Projects
No Similar Projects information available for 5K43TW011583-05